SCHEMBL7265102

SCHEMBL7265102

NC1CCCC=C1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9028184 1.00
SCHEMBL8786738 1.00
SCHEMBL17293582 0.84
SCHEMBL17293338 0.84
SCHEMBL17293469 0.84
SCHEMBL24425971 0.72
SCHEMBL13494257 0.72
SCHEMBL7431017 0.72
SCHEMBL13370650 0.70
SCHEMBL4017747 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729456-B1 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDOL-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMA INC (US) 1997-12-17 EP disclosed
EP-0729456-A1 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDOL-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMACEUTICALS INC. (US) 1996-09-04 EP disclosed
US-5508411-A Process for preparing (S)-1-[2(S)-(1,3-dihyrdro-1,3-dioxo-isoindo-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4,-tetrahydro-2-pyridine-carboxylic acid methyl ester MERRELL PHARMACEUTICALS INC. 1996-04-16 US disclosed
US-5502253-A Cyclohex-2-enyl acetamides MERRELL PHARMACEUTICALS INC. 1996-03-26 US disclosed
WO-1995014663-A2 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDO-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMACEUTICALS INC. (US) 1995-06-01 WO disclosed
EP-0322914-B1 Novel sulfhydryl containing tricyclic lactams and their pharmacological methods of use MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
EP-0249223-B1 NOVEL ANTIHYPERTENSIVE AGENT MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-14 EP disclosed
US-5095110-A Process for the preparation of sulfhydryl containing tricyclic lactams MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-10 US disclosed
US-4973585-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS (US) 1990-11-27 US disclosed
EP-0322914-A2 Novel sulfhydryl containing tricyclic lactams and their pharmacological methods of use MERRELL DOW PHARMACEUTICALS INC. (US) 1989-07-05 EP disclosed
US-4824832-A INHIBIT ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-25 US disclosed
CN-87104166-A Antihypertensive medicine 1988-01-20 CN disclosed